|
Originally published In Press as doi:10.1074/jbc.M202999200 on May 16, 2002
J. Biol. Chem., Vol. 277, Issue 30, 26846-26851, July 26, 2002
Chimerism Reveals a Role for the Streptokinase -Domain in
Nonproteolytic Active Site Formation, Substrate, and Inhibitor
Interactions*
Inna P.
Gladysheva,
Irina Y.
Sazonova,
Shakeel A.
Chowdhry,
Lin
Liu,
Ryan B.
Turner, and
Guy L.
Reed
From the Cardiovascular Biology Laboratory, Harvard School of
Public Health and the Massachusetts General Hospital, Boston,
Massachusetts 02114
Streptokinase (SK) and staphylokinase form
cofactor-enzyme complexes that promote the degradation of fibrin
thrombi by activating human plasminogen. The unique abilities of
streptokinase to nonproteolytically activate plasminogen or to alter
the interactions of plasmin with substrates and inhibitors may be the
result of high affinity binding mediated by the streptokinase
-domain. To examine this hypothesis, a chimeric streptokinase,
SK swap, was created by swapping the SK -domain with the
homologous -domain of Streptococcus uberis Pg activator
(SUPA or PauA, SK uberis), a streptokinase that cannot activate human
plasminogen. SK swap formed a tight complex with microplasminogen
with an affinity comparable with streptokinase. The SK swap-plasmin
complex also activated human plasminogen with catalytic efficiencies
(kcat/Km = 16.8 versus 15.2 µM 1 min 1) comparable with
streptokinase. However, SK swap was incapable of nonproteolytic
active site generation and activated plasminogen by a staphylokinase
mechanism. When compared with streptokinase complexes,
SK swap-plasmin and SK swap-microplasmin complexes had altered
affinities for low molecular weight substrates. The SK swap-plasmin
complex also was less resistant than the streptokinase-plasmin complex
to inhibition by 2-antiplasmin and was readily inhibited by soybean trypsin inhibitor. Thus, in addition to mediating high affinity binding to plasmin(ogen), the streptokinase -domain is
required for nonproteolytic active site generation and specifically modulates the interactions of the complex with substrates and inhibitors.
*
This work was supported in part by National Institutes of
Health Grant HL-57314 (to G. L. R.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: Cardiovascular
Biology Laboratory, HSPH II-127, 677 Huntington Ave., Boston, MA 02115. Tel.: 617-432-4992; Fax: 617-432-0033; E-mail:
guyreed@hsph.harvard.edu.
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
I. Y. Sazonova, B. R. Robinson, I. P. Gladysheva, F. J. Castellino, and G. L. Reed
{alpha} Domain Deletion Converts Streptokinase into a Fibrin-dependent Plasminogen Activator through Mechanisms Akin to Staphylokinase and Tissue Plasminogen Activator
J. Biol. Chem.,
June 11, 2004;
279(24):
24994 - 25001.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. P. Gladysheva, R. B. Turner, I. Y. Sazonova, L. Liu, and G. L. Reed
Coevolutionary patterns in plasminogen activation
PNAS,
August 5, 2003;
100(16):
9168 - 9172.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|